Skip to main content
. 2022 Mar 31;82(7):753–762. doi: 10.1002/pros.24328

Figure 6.

Figure 6

Repeat cycling between high and low levels of androgen receptor (AR) activity by either blocking androgens or giving supraphysiologic testosterone (BAT) may be a new therapeutic approach that takes advantage of prostate cancer cell ability to adapt to changing testosterone levels in the environment. [Color figure can be viewed at wileyonlinelibrary.com]